Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Novo Nordisk warns on sales and operating profit:

This article was originally published in Clinica

Executive Summary

Danish company Novo Nordisk has warned that its first-quarter sales have been lower than expected and that full-year sales are not likely to reach previously forecast levels. The company has reduced expectations for full-year operating profit growth from 15% to 5-10%. The Bagsvaerd-based company attributes the poor performance in part to the fact that sales growth of insulin products in Europe have been hit by a slower than expected conversion to analogs and new devices.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT066029

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel